J 2023

Single-center long-term results of vagus nerve stimulation for pediatric epilepsy: a 10-17-year follow-up study

CHRASTINA, Jan, Ondřej HORÁK, Michal RYZÍ, Milan BRÁZDIL, Zdeněk NOVÁK et. al.

Základní údaje

Originální název

Single-center long-term results of vagus nerve stimulation for pediatric epilepsy: a 10-17-year follow-up study

Autoři

CHRASTINA, Jan (203 Česká republika, garant, domácí), Ondřej HORÁK (203 Česká republika, domácí), Michal RYZÍ (203 Česká republika, domácí), Milan BRÁZDIL (203 Česká republika, domácí), Zdeněk NOVÁK (203 Česká republika, domácí), Tomáš ZEMAN (203 Česká republika, domácí) a Pavlína DANHOFER (203 Česká republika, domácí)

Vydání

Childs nervous system, NEW YORK, SPRINGER, 2023, 0256-7040

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30210 Clinical neurology

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 1.400 v roce 2022

Kód RIV

RIV/00216224:14110/23:00134637

Organizační jednotka

Lékařská fakulta

UT WoS

000992036000001

Klíčová slova anglicky

Seizure; Stimulation treatment; Stimulation responder; Palliative surgery

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 14. 2. 2024 19:56, Mgr. Eva Dubská

Anotace

V originále

PurposeA retrospective study, based on a prospectively built database, presents the results of long-term follow-up care of pediatric vagus nerve stimulation (VNS) patients in terms of seizure outcome, surgical aspects, the potential impact of maturation, and medication changes.MethodsFrom a prospectively built database, 16 VNS patients (median age 12.0 years, range 6.0 to 16.0 years; median seizure duration 6.5 years, range 2.0 to 15.5 years) followed for at least 10 years were graded as non-responder - NR (seizure frequency reduction < 50%), responder - R (reduction >= 50% and < 80%), and 80% responder - 80R (reduction >= 80%). Data about surgical aspects (battery replacement, system complications), seizure dynamics, and medication changes were taken from the database.ResultsThe early percentages of good results (80R + R) were 43.8% (year 1), 50.0% (year 2), and 43.8% (year 3). These percentages remained stable between years 10 and 12 (50% year 10; 46.7% year 11; 50% year 12) and increased in years 16 (60%) and 17 (75%). Depleted batteries were replaced in ten patients, six of whom were either R or 80R. In the four NR, the indication for replacement was improved quality of life. Three patients had VNS explanted or switched off-one had repeated asystolia and two were NR. The effect of hormonal changes in menarche on seizure was not proven. During the study, antiseizure medication was changed in all patients.ConclusionsThe study proved the efficacy and safety of VNS in pediatric patients over an exceptionally long follow-up period. The demand for battery replacements indicates a positive treatment effect.

Návaznosti

NV19-04-00343, projekt VaV
Název: Predikce Efektu Stimulace u pacientů s Epilepsií (PRESEnCE) (Akronym: PRESEnCE)
Investor: Ministerstvo zdravotnictví ČR, Prediction of Stimulation Efficacy in Epilepsy